Current Edition

Antibody-drug Conjugates_ A Trojan Horse Story
Current Features

Antibody-drug Conjugates: A Trojan Horse Story

According to the World Health Organization, cancer is responsible for 10 million deaths per year, and it is considered as the second leading cause of …

Continue Reading →
Adapting Your Preclinical Animal Model Strategies
Current Features

Adapting Your Preclinical Animal Model Strategies for a New World

Investigators in the commercial and non-profit sectors have always faced pressure to accelerate their work while balancing the need for quality and the realities of …

Continue Reading →
Standard vs. Hybrid FIH Trials_Advantages and Challenges
Current Features

Standard vs. Hybrid FIH Trials: Advantages and Challenges

First in human (FIH) studies are the key translational studies from preclinical to further clinical development processes. The goal of FIH studies is to investigate …

Continue Reading →
Intricacies and Future Considerations for the Cell and Gene Therapy
Current Features

Intricacies and Future Considerations for the Cell and Gene Therapy Cold Chain

The rapidly growing field of cell and gene therapy is both exciting and confusing to many, including those who work in the medical community and …

Continue Reading →
Four Factors for a Biopharmaceutical Manufacturer to Consider when Developing
Current Features

Four Factors for a Biopharmaceutical Manufacturer to Consider when Developing and Managing a Single-use Supply Chain

Single-use technologies are becoming widely utilised in the biopharmaceutical industry for the benefit of offering a more flexible, cost-effective approach to cGMP manufacturing. Single-use technologies …

Continue Reading →